Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 79Unknown 23Recruiting 23Terminated 19Active not recruiting 17Withdrawn 7Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 7NIH 1INDUSTRY 1

Study Type

Interventional 5Observational 2

Sponsor

Cancer Type

Dermatologic 7

Conditions

Breast Neoplasms 333Neoplasms 221Prostatic Neoplasms 197Carcinoma, Non-Small-Cell Lung 156Lung Neoplasms 135Pancreatic Neoplasms 118Colorectal Neoplasms 103Neoplasm Metastasis 100Carcinoma, Hepatocellular 96Leukemia, Myeloid, Acute 94Multiple Myeloma 91Brain Neoplasms 89Lymphoma 86Head and Neck Neoplasms 76Melanoma 73Ovarian Neoplasms 72Leukemia 71Leukemia, Lymphocytic, Chronic, B-Cell 69Glioblastoma 69Precursor Cell Lymphoblastic Leukemia-Lymphoma 66Colonic Neoplasms 61Recurrence 59Lymphoma, Non-Hodgkin 54Rectal Neoplasms 50Hematologic Neoplasms 50Lymphoma, Follicular 49Glioma 49Squamous Cell Carcinoma of Head and Neck 47Lymphoma, Large B-Cell, Diffuse 47Carcinoma, Renal Cell 47

Interventions

trametinib 1olaparib 1durvalumab 1cediranib 1Vorinostat 1Magnetic Resonance Spectroscopy 1Biopsy, Fine-Needle 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Uveal Melanoma × Clear all
NCT05482074 2024-01-19

Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2

Dana-Farber Cancer Institute

Phase 2 Withdrawn
Dermatologic

Uveal Melanoma, Melanoma

NCT05677373 2023-08-18

Testing the Safety and Effectiveness of Combining Two Drugs, PLX2853 and Trametinib in the Treatment of Advanced Uveal Melanoma

Alliance for Clinical Trials in Oncology

Phase 1/2 Withdrawn
Dermatologic

Uveal Melanoma

NCT01930968 2022-02-23

Definity for Ultrasound of Intraocular Tumors

Emory University

Withdrawn
Dermatologic

Uveal Melanoma

NCT04184518 2020-06-02

CEDUVEAL-M

Grupo Español Multidisciplinar de Melanoma

Phase 2 Withdrawn
Dermatologic

Uveal Melanoma, Neoplasm Metastasis

NCT03022565 2020-02-06

Vorinostat in Patients With Class 2 High Risk Uveal Melanoma

University of Miami

Phase EARLY_PHASE1 Withdrawn
Dermatologic

Uveal Melanoma

NCT00406120 2018-06-26

Validation of a Molecular Prognostic Test for Eye Melanoma

Washington University School of Medicine

Withdrawn
Dermatologic

Uveal Melanoma, Choroid Neoplasms, Melanoma, Neoplasm Metastasis, Uveal Neoplasms, Iris Neoplasms

NCT00621439 2013-12-02

Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye

Emory University

Phase NA Withdrawn
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡